4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with glycogen in 1 studies
Studies (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Trials (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Recent Studies (post-2010) (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Studies (glycogen) | Trials (glycogen) | Recent Studies (post-2010) (glycogen) |
---|---|---|---|---|---|
62 | 0 | 14 | 25,566 | 576 | 3,794 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuzawa, Y; Hara, T; Kakumu, S; Kusunoki, M; Miyata, T; Nakamura, T; Nakaya, Y; Ogawa, H; Sakakibara, F; Suga, T; Tsutsumi, K | 1 |
1 other study(ies) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and glycogen
Article | Year |
---|---|
Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886.
Topics: Animals; Benzamides; Blood Glucose; Body Weight; Cholesterol; Dietary Fats; Enzyme Activation; Glucose Clamp Technique; Glycogen; Hypolipidemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Lipoprotein Lipase; Liver; Male; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Triglycerides | 2002 |